United Laboratories International Holdings
United Laboratories International Holdings Limited, commonly referred to as United Laboratories, is a prominent player in the pharmaceutical and healthcare industry, headquartered in Hong Kong. Founded in 1992, the company has established a strong presence across Asia, particularly in China, where it operates extensive manufacturing and distribution networks. Specialising in the production of a wide range of pharmaceutical products, including generic drugs and active pharmaceutical ingredients, United Laboratories is recognised for its commitment to quality and innovation. The company’s state-of-the-art facilities and adherence to international standards set it apart in a competitive market. With a robust market position, United Laboratories has achieved significant milestones, including numerous certifications and awards that underscore its dedication to excellence. As a trusted name in healthcare, the company continues to expand its reach and enhance its product offerings, contributing to improved health outcomes across the region.
DitchCarbon Score
How does United Laboratories International Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
United Laboratories International Holdings's score of 10 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
United Laboratories International Holdings's reported carbon emissions
In 2023, United Laboratories International Holdings reported total carbon emissions of approximately 1,793,319,000 kg CO2e. This figure includes 1,412,549,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 377,650,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity. Additionally, Scope 3 emissions, primarily from business travel, accounted for about 3,120,000 kg CO2e. In 2022, the company achieved a total of approximately 1,216,069,000 kg CO2e in emissions, with Scope 1 emissions at 965,987,000 kg CO2e and Scope 2 emissions at 247,666,000 kg CO2e. The Scope 3 emissions for that year were around 2,416,000 kg CO2e. The emissions data indicates a significant increase in total emissions from 2022 to 2023, rising from approximately 1,216,069,000 kg CO2e to 1,793,319,000 kg CO2e. This trend raises concerns about the company's climate commitments, as there are currently no disclosed reduction targets or initiatives aimed at mitigating these emissions. Overall, United Laboratories International Holdings, headquartered in Hong Kong, faces challenges in addressing its carbon footprint and aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 979,680,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 |
| Scope 2 | 194,041,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 3,086,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
United Laboratories International Holdings is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
